I

n what could be a big win for the pharmaceutical industry, legislation is close to being signed into law in New York State that would absolve drug makers from paying for so-called drug take-back programs.

Identical bills recently passed the state Senate and Assembly that would, instead, require chain pharmacies to cover the costs, a move that bucks a growing trend on the West Coast, where drug makers have increasingly been forced by local governments to pay for these programs.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.